Obesity Medicine 2025 - Anti-Obesity Medications in Complex Cases (Recorded)
This session explores the use of anti-obesity medications through complex case-based scenarios, providing a hands-on approach to understanding their application in real-world situations. Attendees will learn through challenging patient cases, considering factors such as comorbidities, contraindications, and treatment resistance. The session emphasizes evidence-based strategies and personalized treatment plans for these complex cases.
CME/CE Expiration Date: 4/27/28
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.
Louis Aronne, MD, FACP, DABOM
Physican
Weill Cornell Medicine
Available Credit
- 1.00 AMA PRA Category 1 Credit™The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Obesity Medicine Association designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the commensurate amount with the extent of their participation in the activity.